First Horizon Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $938 | Sell |
34
-124
| -78% | -$3.42K | ﹤0.01% | 2176 |
|
|
2025
Q1 | $4.48K | Buy |
158
+64
| +68% | +$1.81K | ﹤0.01% | 1827 |
|
|
2024
Q4 | $3.91K | Sell |
94
-179
| -66% | -$7.44K | ﹤0.01% | 1853 |
|
|
2024
Q3 | $18.2K | Sell |
273
-44
| -14% | -$2.94K | ﹤0.01% | 1397 |
|
|
2024
Q2 | $37.6K | Buy |
317
+22
| +7% | +$2.61K | ﹤0.01% | 1049 |
|
|
2024
Q1 | $31.4K | Buy |
295
+253
| +602% | +$27K | ﹤0.01% | 1165 |
|
|
2023
Q4 | $4.18K | Sell |
42
-75
| -64% | -$7.46K | ﹤0.01% | 1844 |
|
|
2023
Q3 | $12.1K | Buy |
117
+31
| +36% | +$3.2K | ﹤0.01% | 1442 |
|
|
2023
Q2 | $10.4K | Buy |
86
+30
| +54% | +$3.65K | ﹤0.01% | 1527 |
|
|
2023
Q1 | $8.6K | Sell |
56
-20
| -26% | -$3.07K | ﹤0.01% | 1611 |
|
|
2022
Q4 | $13.7K | Buy |
76
+39
| +105% | +$7.01K | ﹤0.01% | 1411 |
|
|
2022
Q3 | $3K | Sell |
37
-54
| -59% | -$4.38K | ﹤0.01% | 1909 |
|
|
2022
Q2 | $13K | Buy |
91
+77
| +550% | +$11K | ﹤0.01% | 1473 |
|
|
2022
Q1 | $2K | Sell |
14
-126
| -90% | -$18K | ﹤0.01% | 1465 |
|
|
2021
Q4 | $34K | Buy |
140
+14
| +11% | +$3.4K | ﹤0.01% | 1086 |
|
|
2021
Q3 | $48K | Buy |
126
+101
| +404% | +$38.5K | ﹤0.01% | 922 |
|
|
2021
Q2 | $5K | Sell |
25
-60
| -71% | -$12K | ﹤0.01% | 1539 |
|
|
2021
Q1 | $11K | Buy |
85
+22
| +35% | +$2.85K | ﹤0.01% | 1262 |
|
|
2020
Q4 | $6K | Buy |
63
+21
| +50% | +$2K | ﹤0.01% | 1181 |
|
|
2020
Q3 | $2K | Sell |
42
-62
| -60% | -$2.95K | ﹤0.01% | 1312 |
|
|
2020
Q2 | $6K | Buy |
+104
| New | +$6K | ﹤0.01% | 1141 |
|